SDIC Venture Capital

Beijing Surgerii Technology Co., Ltd. specializes in the research, development, production, and sale of minimally invasive surgical robot systems in China. Founded in 2014 and based in Beijing, the company focuses on innovative technologies, particularly the next generation of flexible continuum robotic arms. Surgerii Technology aims to transform clinical practices through its single-hole and porous laparoscopic robot systems, enhancing the standard of care in minimally invasive surgeries. With a commitment to independent research and development, the company leverages its expertise in system design and integration to advance the medical equipment industry in China.

SAFE Pharmaceutical, officially known as Beijing Saifu Medical Research Institute Co., Ltd., operates as a Contract Research Organization (CRO) specializing in pharmaceutical research and development services. The company collaborates with esteemed institutions such as the Shanghai Institute of Materia Medica and the National Drug Safety Evaluation and Research Center, leveraging their expertise to enhance its operational capabilities. With a core team comprised of experienced researchers from prestigious scientific organizations, SAFE Pharmaceutical offers comprehensive services that include R&D consulting, toxicology evaluations, and clinical trial design. This integrated approach allows pharmaceutical developers to efficiently advance their product research and development initiatives, supported by strong technical expertise and management experience in drug development and GLP compliance.

Grace Laser Technology Co., Ltd., established in 2014 and headquartered in Beijing, China, specializes in the development of laser devices for various applications, including scientific research, industrial processing, and medical aesthetics. The company is committed to advancing the national laser industry and aims to establish a renowned domestic laser brand. Grace Laser possesses a comprehensive research and development, production, and quality management system, which enables it to deliver high-quality laser products and services to its clients.

TBSTest Technology is a Beijing-based company that develops, manufactures, and sells automatic test equipment for integrated circuits (IC). Founded in 2017, it specializes in research and development of ultra-large-scale integrated circuit test systems, primarily targeting enterprise users involved in IC design, production, packaging, and testing. The company's product offerings include test boards, software solutions, and memory systems, alongside comprehensive pre-sales and after-sales support for its equipment and accessories. TBSTest serves a diverse clientele, including scientific research institutions, universities, and various clients in the semiconductor industry. In addition to its headquarters in Beijing, the company has branch offices in Xi’an City and Shanghai, China, as well as in Suwon, South Korea.

TBSTest Technology is a Beijing-based company that develops, manufactures, and sells automatic test equipment for integrated circuits (IC). Founded in 2017, it specializes in research and development of ultra-large-scale integrated circuit test systems, primarily targeting enterprise users involved in IC design, production, packaging, and testing. The company's product offerings include test boards, software solutions, and memory systems, alongside comprehensive pre-sales and after-sales support for its equipment and accessories. TBSTest serves a diverse clientele, including scientific research institutions, universities, and various clients in the semiconductor industry. In addition to its headquarters in Beijing, the company has branch offices in Xi’an City and Shanghai, China, as well as in Suwon, South Korea.

RemeGen, Ltd. is a biopharmaceutical company based in Yantai, Shandong Province, China, focused on addressing unmet medical needs for patients with life-threatening conditions. The company specializes in the research, development, manufacturing, and commercialization of innovative biologics, particularly monoclonal antibodies and antibody-drug conjugates. RemeGen's leading products include Telitacicept, aimed at treating systemic lupus erythematosus, and Disitamab Vedotin, designed for various cancers. The company’s therapeutic offerings target significant health issues, including autoimmune diseases, oncology, and ophthalmology. With operations in both China and the United States, RemeGen primarily generates its revenue from the Chinese market.

Beijing Biostar Technologies, Ltd., established in 2002, is a biopharmaceutical company based in Beijing, China. It specializes in the development of anti-tumor chemotherapy biopharmaceutical molecules, with a focus on creating innovative small molecule chemical drugs for cancer treatment. The company was founded by a team of Chinese scientists led by Dr. Tang Li and Dr. Qiu Rongguo, who previously worked in the United States. Biostar Technologies pioneered the creation of new anti-cancer drugs based on epothilone in China and its technology is recognized as being at the international advanced level.

Zshield Inc. is a Beijing-based company specializing in cyberspace data security and big data business risk management. Established in 2014, it is recognized as the first high-tech firm in China to leverage big data technologies in addressing emerging information security vulnerabilities. Zshield develops advanced integrated information security solutions that utilize lightweight virtualization, deep learning, and big data analysis to provide effective monitoring of server and terminal security. Its offerings include a comprehensive information security platform and the AndunTM ZS-ISP, which supports both government and enterprise clients in navigating the complexities of modern computing environments, including cloud computing and mobile applications. As traditional security measures struggle to cope with new threats, Zshield's innovative approach aims to fortify businesses against the evolving landscape of information security challenges.

Eucure Biopharma, established in 2016 and headquartered in Beijing, China, is a biotechnology company focused on the discovery and development of innovative immuno-oncology targeted antibodies. Its pipeline comprises eight drug candidates, primarily targeting immune checkpoints, with several in the clinical trial application stage. The company offers services such as antibody production, in vivo and in vitro drug efficacy testing, and aims to improve the survival rate of tumor patients by developing effective antibody treatments.

Beijing SkyGuard Network Security Technologies LLC, founded in 2015 and based in Beijing, China, specializes in network information security technology services. The company focuses on developing data security technologies that prioritize the protection of individuals and their data. In addition to its core technology offerings, SkyGuard provides consulting services, as well as pre-sales and after-sales technical support for enterprise users, ensuring comprehensive assistance throughout the customer journey.

Eucure Biopharma, established in 2016 and headquartered in Beijing, China, is a biotechnology company focused on the discovery and development of innovative immuno-oncology targeted antibodies. Its pipeline comprises eight drug candidates, primarily targeting immune checkpoints, with several in the clinical trial application stage. The company offers services such as antibody production, in vivo and in vitro drug efficacy testing, and aims to improve the survival rate of tumor patients by developing effective antibody treatments.

Twenty First Century Aerospace Technology Co., Ltd is a Beijing-based company specializing in commercial earth observation (EO) satellites and geospatial information services. Founded in 2001, it operates a constellation of small EO satellites, including a 1-meter optical satellite, and manages satellite control and image tasking stations. The company provides a comprehensive range of services throughout the space geo-information value chain, including satellite procurement, data acquisition, image processing, and geo-information services. Its offerings encompass programmed and archived imaging data, value-added images, and various spatial remote sensing services. Additionally, the company develops software for image data processing, smart satellite resource management, and intelligent tasking. Its geo-information services cater to diverse applications, including land cover analysis, change detection, and 3D simulations, supporting sectors such as urban management, natural resources, and emergency response. With a focus on both domestic and international markets, the company leverages self-developed technology and algorithms to deliver high-quality image data and big data solutions for its clients.

Zshield Inc. is a Beijing-based company specializing in cyberspace data security and big data business risk management. Established in 2014, it is recognized as the first high-tech firm in China to leverage big data technologies in addressing emerging information security vulnerabilities. Zshield develops advanced integrated information security solutions that utilize lightweight virtualization, deep learning, and big data analysis to provide effective monitoring of server and terminal security. Its offerings include a comprehensive information security platform and the AndunTM ZS-ISP, which supports both government and enterprise clients in navigating the complexities of modern computing environments, including cloud computing and mobile applications. As traditional security measures struggle to cope with new threats, Zshield's innovative approach aims to fortify businesses against the evolving landscape of information security challenges.